Fresenius SE & Co. KGaA
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
RSS
|
German
Who we are
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Corporate Governance
Business Development / M&A
Environment
History
Frequently Asked Questions
Investor Relations
Fresenius Share/ADR
Credit Relations
News
Publications
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Press
Press Releases
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Press Kit 100 Years
Health Care
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
Calendar
Links
Contacts
Career
SEARCH
Press Releases
All
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Business & Finance
Quarterly Results
Medicine & Research
Order Service
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Press Kit 100 Years
Share Price
Next Event
30.07.2013
Report on 1st half 2013
>>>
Further events
>>>
All - 2004
21.12.2004
Fresenius Medical Care AG strengthens leading position in emerging European markets
Text as PDF file
13.12.2004
Fresenius Medical Care AG Refinances Senior Credit Facilities
Text as PDF file
08.12.2004
Fresenius Kabi: Market leader builds on success
Text as PDF file
07.12.2004
Fresenius Kabi strengthens position in central and eastern Europe
Text as PDF file
02.11.2004
1st-3rd Quarter 2004: Fresenius continues successful revenue and earnings development, raises earnings outlook
Text as PDF file
02.11.2004
Fresenius Medical Care reports Third Quarter and Nine Months Results 2004
Text as PDF file
29.10.2004
Fresenius ProServe to focus on core activities - Agreement reached on the sale of nursing care business
Text as PDF file
27.10.2004
US subsidiaries of Fresenius Medical Care receive subpoenas
Text as PDF file
19.10.2004
Fresenius announces changes to the Management Board
Text as PDF file
06.09.2004
Fresenius Kabi is expanding its market presence in Australia
Text as PDF file
04.08.2004
First Half 2004: Fresenius raises sales and earnings outlook
Text as PDF file
04.08.2004
Fresenius Medical Care reports Second Quarter and Six Months Results 2004
Text as PDF file
18.05.2004
Fresenius Kabi is expanding it's leading market position in South Africa
Text as PDF file
06.05.2004
Fresenius announces First Quarter Results 2004
Text as PDF file
06.05.2004
Fresenius Medical Care reports First Quarter 2004 results; First quarter ahead of expectations
Text as PDF file
19.03.2004
Fresenius receives Orphan Drug Designation for antibody removab® to treat patients with ovarian cancer
Text as PDF file
17.03.2004
Fresenius AG appoints new Member of the Management Board
Text as PDF file
25.02.2004
Fresenius Medical Care AG reports Fourth Quarter and Full Year Results 2003
Text as PDF file
25.02.2004
Fresenius announces results of Financial Year 2003
Text as PDF file
15.01.2004
Capital Market Day Fresenius Biotech: Fresenius concentrates biotechnology activities on antibody and innovative cell therapies
Text as PDF file
Home
>
Press
>
Press Releases
>
All
>
2004
